Marc Pritzker, M.D.

Marc Pritzker (pritz001@umn.edu) is a Professor of Medicine in the Cardiovascular Division at the University of Minnesota. He is a graduate of Amherst College and the University of Minnesota Medical School. He completed his residency and chief residency at the University of Minnesota Hospitals and Clinics. He received his training in cardiology under the watchful eyes of Dr. Jay Cohn and Dr. Howard Burchell at the University of Minnesota and Abbott-Northwestern Hospital in Minneapolis. He completed a research year in cardiovascular pathology with Dr. Jesse Edwards at Miller hospital in St. Paul and an additional year as an electrophysiology fellow under the guidance of Dr. David Benditt. Subsequently Dr. Pritzker joined the Minneapolis Heart institute as one of its initial members and served as director of the heart failure, transplantation, mechanical circulatory assistance and pulmonary hypertension service. Dr. Pritzker was appointed to several positions, including president of the Minneapolis Heart Institute, president of the Minneapolis heart Institute Foundation and chair of cardiovascular medicine and surgery at abbott-northwestern hospital. He has co-authored more than 40 papers in the areas of mechanical circulatory assistance, cardiac arrhythmia evaluation and treatment, the treatment of collagen vascular disease vasospasm with prostacyclin and/or botulism toxin, transplant vasculopathy and the treatment of pulmonary artery hypertension.

Research projects available with Dr. Pritzker include the following:

  • Iron deficiency anemia and pulmonary artery hypertension
  • The use of epigenetic modification for the treatment of pulmonary hypertension and/or diastolic dysfunction
  • Modification of pulmonary artery compliance to improve outcomes in pulmonary hypertension
  • The use of NMR spectroscopy to assess therapeutic interventions in pulmonary hypertension and right heart failure
  • The use of angiopoietin 2 antagonism to prevent transplant vasculopathy 6. IL 6 antagonism for the treatment of pulmonary artery hypertension